Acamprosate interactions

Acamprosate (Campral) has 12 documented interactions across the FDA labels and fact sheets we index: 0 major, 0 moderate, 1 minor, and 11 where a label reports no significant interaction. Each entry below quotes the sentence behind it. This drug page is a starting point, not a verdict for your situation.

What Acamprosate looks like

All 6 versions
Acamprosate 333 mg tablet: white, round, 10 mm, imprinted 333.
333
333 mg · white · round · 10 mm
Carilion Materials Managem…
Acamprosate 333 mg tablet: white, round, 10 mm, imprinted 569.
569
333 mg · white · round · 10 mm
Zydus Pharmaceuticals (USA)
Acamprosate 333 mg tablet: white, round, 10 mm, imprinted 435.
435
333 mg · white · round · 10 mm
Glenmark Pharmaceuticals
Acamprosate 333 mg tablet: white, round, 10 mm, imprinted AC476.
AC476
333 mg · white · round · 10 mm
Somerset Therapeutics

Renderings from the FDA labels' product listings: color, shape, size, and imprint. 6 documented versions from 7 labelers.

Interactions from the label

Minor mentions (1)

  • AlcoholAlcoholMinor

    Alcohol Withdrawal Use of acamprosate calcium does not eliminate or diminish withdrawal symptoms. (Acamprosate label, Warnings and precautions)

No significant interaction reported (11)

  • Alvimopanopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • DiazepambenzodiazepineNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • DisulfiramCYP2C9 inhibitorNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Methylnaltrexoneopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Naldemedineopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Nalmefeneopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Naloxegolopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Naloxoneopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Naltrexoneopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Naltrexone and bupropionopioid antagonistNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

  • Pentazocine and naloxoneopioidNo interaction

    The pharmacokinetics of acamprosate are not affected by alcohol, diazepam, or disulfiram, and clinically important interactions between naltrexone and acamprosate were not observed [ see Clinical Pharmacology ( 12.3 ) ]. (Acamprosate label, Drug interactions)

Check Acamprosate against everything you take. Add your full list; every pair is checked at once.

Open in the checker

Not medical advice. Severity reflects the label's wording, not your circumstances. A "major" flag can be routine under supervision and a "minor" one can matter at high doses. Ask a pharmacist.